<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20982" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biochemistry, Electron Transport Chain</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmad</surname>
            <given-names>Maria</given-names>
          </name>
          <aff>Georgia Institute of Technology</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wolberg</surname>
            <given-names>Adam</given-names>
          </name>
          <aff>Lake Erie College of Osteopathic Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kahwaji</surname>
            <given-names>Chadi I.</given-names>
          </name>
          <aff>Universtity of California, Irvine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Maria Ahmad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Adam Wolberg declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chadi Kahwaji declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20982.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The electron transport chain is a series of four protein complexes that couple redox reactions, creating an electrochemical gradient that leads to the creation of ATP in a complete system named oxidative phosphorylation. It occurs in mitochondria in both cellular respiration and in chloroplasts for photosynthesis. In the former, the electrons come from breaking down organic molecules, and energy is released. In the latter, the electrons enter the chain after being excited by light, and the energy released is used to build carbohydrates.</p>
      </sec>
      <sec id="article-20982.s2" sec-type="Fundamentals">
        <title>Fundamentals</title>
        <p>Aerobic cellular respiration is made up of three parts: glycolysis, the citric acid (Krebs) cycle, and oxidative phosphorylation. In glycolysis, glucose metabolizes into two molecules of pyruvate, with an output of ATP and nicotinamide adenine dinucleotide (NADH). Each pyruvate oxidizes into acetyl CoA and an additional molecule of NADH and carbon dioxide (CO2). The acetyl CoA is then used in the citric acid cycle, which is a chain of chemical reactions that produce CO2, NADH, flavin adenine dinucleotide (FADH2), and ATP. In the final step, the three NADH and one FADH2 amassed from the previous steps are used in oxidative phosphorylation, to make water and ATP.</p>
        <p>Oxidative phosphorylation has two parts: the electron transport chain (ETC) and chemiosmosis. The ETC is a collection of proteins bound to the inner mitochondrial membrane and organic molecules, which electrons pass through in a series of redox reactions, and release energy. The energy released forms a proton gradient, which is used in chemiosmosis to make a large amount of ATP by the protein ATP-synthase.</p>
        <p>Photosynthesis is a metabolic process that converts light energy into chemical energy to build sugars. In the light-dependent reactions, light energy and water are used to make ATP, NADPH, and oxygen (O2). The proton gradient used to make the ATP forms via an electron transport chain. In the light-independent reactions, sugar is made from the ATP and NADPH from the previous reactions.</p>
      </sec>
      <sec id="article-20982.s3" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>In the electron transport chain (ETC), the electrons go through a chain of proteins that increases its reduction potential and causes a release in energy. Most of this energy is dissipated as heat or utilized to pump hydrogen ions (H+) from the mitochondrial matrix to the intermembrane space and create a proton gradient. This gradient increases the acidity in the intermembrane space and creates an electrical difference with a positive charge outside and a negative charge inside. The ETC proteins in a general order are complex I, complex II, coenzyme Q, complex III, cytochrome C, and complex IV.</p>
        <list list-type="bullet">
          <list-item>
            <p>Complex I, also known as ubiquinone oxidoreductase, is made up of NADH dehydrogenase, flavin mononucleotide (FMN), and eight iron-sulfur (Fe-S) clusters. The NADH donated from glycolysis, and the citric acid cycle is oxidized here, transferring 2 electrons from NADH to FMN. Then they are transferred to the Fe-S clusters and finally from Fe-S to coenzyme Q. During this process, 4 hydrogen ions pass from the mitochondrial matrix to the intermembrane space, contributing to the electrochemical gradient. Complex I may also play an important role in causing apoptosis in programmed cell death.<xref ref-type="bibr" rid="article-20982.r1">[1]</xref><xref ref-type="bibr" rid="article-20982.r2">[2]</xref><xref ref-type="bibr" rid="article-20982.r3">[3]</xref><xref ref-type="bibr" rid="article-20982.r4">[4]</xref><xref ref-type="bibr" rid="article-20982.r1">[1]</xref>
<list list-type="bullet"><list-item><p>(NADH + H+) + CoQ + 4 H+(matrix) -&#x0003e; NAD+ + CoQH2 + 4 H+(intermembrane)</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Complex II, also known as succinate dehydrogenase, accepts electrons from succinate (an intermediate in the citric acid cycle) and acts as a second entry point to the ETC. When succinate oxidizes to fumarate, 2 electrons are accepted by FAD within complex II. FAD passes them to Fe-S clusters and then to coenzyme Q, similar to complex I. However; no protons are translocated across the membrane by complex II, therefore less ATP is produced with this pathway.<xref ref-type="bibr" rid="article-20982.r5">[5]</xref><xref ref-type="bibr" rid="article-20982.r6">[6]</xref>
<list list-type="bullet"><list-item><p>Succinate + FAD -&#x0003e; Fumarate + 2 H+(matrix) + FADH2</p></list-item><list-item><p>FADH2 + CoQ -&#x0003e; FAD + CoQH2
<list list-type="bullet"><list-item><p>Glycerol-3-Phosphate dehydrogenase and Acyl-CoA dehydrogenase also accept electrons from glycerol-3-P and fatty acyl-CoA, respectively. Inclusion of these protein complexes allows for the donation to the ETC by cytosolic NADH (glycerol-3-P acts as a shuttle to regenerate cytosolic NAD from NADH) and fatty acids undergoing beta-oxidation within the mitochondria (acyl-CoA is oxidized to enoyl-CoA in the first step, producing FADH2).<xref ref-type="bibr" rid="article-20982.r7">[7]</xref><xref ref-type="bibr" rid="article-20982.r8">[8]</xref></p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Coenzyme Q, also known as ubiquinone (CoQ), is made up of quinone and a hydrophobic tail. Its purpose is to function as an electron carrier and transfer electrons to complex III. Coenzyme Q undergoes reduction to semiquinone (partially reduced, radical form CoQH-) and ubiquinol (fully reduced CoQH2) through the Q cycle.&#x000a0;This process receives further elaboration under Complex III.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Complex III, also known as cytochrome c reductase, is made up of cytochrome b, Rieske subunits (containing two Fe-S clusters), and cytochrome c proteins. A cytochrome is a protein involved in electron transfer that contains a heme group. The heme groups alternate between ferrous (Fe2+) and ferric (Fe3+) states during the electron transfer. Because cytochrome c can only accept a single electron at a time, this process occurs in two steps (the Q cycle), in contrast to the single-step complex I and II pathways. Complex III also releases 4 protons into the intermembrane space at the end of a full Q cycle, contributing to the gradient. Cytochrome c then transfers the electrons one at a time to complex IV.<xref ref-type="bibr" rid="article-20982.r9">[9]</xref><xref ref-type="bibr" rid="article-20982.r10">[10]</xref><xref ref-type="bibr" rid="article-20982.r11">[11]</xref>
<list list-type="bullet"><list-item><p>Q Cycle:&#x000a0;&#x000a0;
<list list-type="bullet"><list-item><p>Step 1 in the Q cycle involves ubiquinol (CoQH2) and ubiquinone (CoQ) binding to two separate sites on complex III. CoQH2 transfers each electron to a different path. One electron goes to Fe-S and then cytochrome c, while the second electron is transferred to cytochrome b and then to CoQ bound at the other site. While this occurs, 2 H+ ions are released into the intermembrane space, contributing to the proton gradient. CoQH2 is now oxidized to ubiquinone and dissociates from the complex. The CoQ bound at the second site enters a transitional CoQH- radical state from accepting one of the electrons.</p></list-item><list-item><p>The second step of the cycle involves a repeat of the first: a new CoQH2 binds to the first site and transfers two electrons like before (and 2 more H+ ions released). Again, one electron passes to cytochrome c and one to cytochrome b, which this time works to reduce CoQH- to CoQH2 before it dissociates from complex III and can be recycled. In this way, one full cycle appears as follows:<xref ref-type="bibr" rid="article-20982.r12">[12]</xref></p></list-item></list>
</p></list-item><list-item><p>2 CoQH2(site 1) + CoQ(site 2) + 2 Cyt c(ox) + 2 H+(matrix) -&#x0003e; 2 CoQ(site 1) + CoQH2(site 2) + 2 Cyt c(red) + 4 H+(intermembrane)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Complex IV, also known as cytochrome c oxidase, oxidizes cytochrome c and transfers the electrons to oxygen, the final electron carrier in aerobic cellular respiration. The cytochrome proteins a and a3, in addition to heme and copper groups in complex IV transfer the donated electrons to the bound dioxygen species, converting it into molecules of water. The free energy from the electron transfer causes 4 protons to move into the intermembrane space contributing to the proton gradient. Oxygen reduces via the following reaction:<xref ref-type="bibr" rid="article-20982.r13">[13]</xref><xref ref-type="bibr" rid="article-20982.r14">[14]</xref>
<list list-type="bullet"><list-item><p>2 cytochrome c(red) + &#x000bd;O2 + 4 H+(matrix) -&#x0003e; 2 cytochrome c(ox) + 1 H2O + 2 H+(intermembrane)</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>ATP synthase, also called complex V, uses the ETC generated proton gradient across the inner mitochondrial membrane to form ATP. ATP-synthase contains up of F0 and F1 subunits, which act as a rotational motor system. F0 is hydrophobic and embedded in the inner mitochondrial membrane. It contains a&#x000a0;proton corridor that is protonated and deprotonated repeatedly as H+ ions flow down the gradient from intermembrane space to matrix. The alternating ionization of F0 causes rotation, which alters the orientation of the F1 subunits. F1 is hydrophilic and faces the mitochondrial matrix. Conformational changes in F1 subunits catalyze the formation of ATP from ADP and Pi. For every 4 H+ ions, 1 ATP is produced. ATP-synthase can also be forced to run in reverse, consuming ATP to produce a hydrogen gradient, as is seen in some bacteria.<xref ref-type="bibr" rid="article-20982.r15">[15]</xref><xref ref-type="bibr" rid="article-20982.r16">[16]</xref><xref ref-type="bibr" rid="article-20982.r17">[17]</xref></p>
      </sec>
      <sec id="article-20982.s4" sec-type="Molecular Level&#x0000d;&#x0000a;">
        <title>Molecular Level
</title>
        <p>Nicotinamide adenine dinucleotide has two forms: NAD+ (oxidized) and NADH (reduced). It is a dinucleotide connected by phosphate groups. One nucleoside has an adenine base and the other nicotinamide. When involved in metabolic redox reactions, the mechanism is as shown in Reaction 1.</p>
        <list list-type="bullet">
          <list-item>
            <p>Reaction 1: RH2 + NAD+ -&#x0003e; R + H+ + NADH</p>
          </list-item>
        </list>
        <p>R is the reactant, for example, sugar.</p>
        <p>NADH enters the ETC at complex I and produces a total of 10 H+ ions through the ETC (4 from complex I, 4 from complex III, and 2 from complex IV). ATP-synthase synthesizes 1 ATP for 4 H+ ions. Therefore, 1 NADH = 10 H+, and 10/4 H+ per ATP = 2.5 ATP per NADH (**some sources round up**). When NADH is oxidized, it breaks into NAD+, H+, and 2 e- as shown in Reaction 2.</p>
        <list list-type="bullet">
          <list-item>
            <p>Reaction 2: NADH -&#x0003e; H+ + &#x000a0;NAD+ + 2 e-</p>
          </list-item>
        </list>
        <p>Flavin adenine dinucleotide has 4 redox states, 3 of them being FAD (quinone, fully oxidized form), FADH- (semiquinone, partially oxidized), and FADH2 (hydroquinone, fully reduced). FAD is made up of an adenine nucleotide and a flavin mononucleotide (FMN), connected by phosphate groups. FMN is synthesized in part from vitamin B2 (riboflavin). FAD contains a highly stable aromatic ring, and FADH2 does not. When FADH2 oxidizes, it becomes aromatic and releases energy, as seen in Reaction 3. This state makes FAD a potent oxidizing agent, with an even more positive reduction potential than NAD. FADH2 enters the ETC at complex II and creates a total of 1.5 ATP (4 H+ from complex III, and 2 H+ from complex IV; 6/4 H+ per ATP = 1.5 ATP per FADH2 **some sources round up**).<xref ref-type="bibr" rid="article-20982.r18">[18]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Reaction 3: FADH2 -&#x0003e; FAD + &#x000a0;2 H+ + 2 e-</p>
          </list-item>
        </list>
        <p>FAD&#x000a0;also functions in several metabolic pathways outside of the ETC, including DNA repair (MTHF repair of UV damage), fatty acid beta-oxidation (acyl-CoA dehydrogenase), and synthesis of coenzymes (CoA, CoQ, heme).</p>
      </sec>
      <sec id="article-20982.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Uncoupling Agents</bold>
</p>
        <p>An uncoupling agent dissociates the electron transport chain from phosphorylation by ATP-synthase, preventing the formation of ATP. Disruption of the phospholipid bilayer of membranes causes a fluid-like and disorganized state, which allows protons to flow through more freely. This proton leak weakens the electrochemical gradient, while also transferring protons without the use of ATP-synthase such that no ATP is produced.&#x000a0;</p>
        <p>While the cell becomes starved of ATP, the ETC will overwork in an attempt to shuttle more and more electrons to ATP-synthase without success. The ETC regularly produces heat as the electrons transfer from one carrier to the next, and this overactivity will raise the body temperature as a result. Additionally, cells will adapt to utilizing fermentation as if in anaerobic conditions; this may cause a type B lactic acidosis in affected patients.<xref ref-type="bibr" rid="article-20982.r19">[19]</xref></p>
        <p>
<italic toggle="yes">Aspirin (Salicylic Acid)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Salicylic acid is an uncoupler. Unique to salicylate poisoning, however, are signs of tinnitus and early respiratory alkalosis, which transitions to a mixed metabolic acidosis and respiratory alkalosis as the process progresses. Early treatment involves activated charcoal if presenting within 1 hour of ingestion, or sodium bicarbonate otherwise.<xref ref-type="bibr" rid="article-20982.r20">[20]</xref></p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Thermogenin</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Thermogenin, also known as uncoupling protein 1 (UCP1), is found in brown adipose tissue. Brown adipose tissue has many small lipid droplets and a high concentration of mitochondria (which provide the "brown" color), in contrast to white adipose tissue, which has a single droplet. This difference supports that brown fat is classically abundantly present in hibernating animals or newborns, who have delayed neurologic thermoregulation (ex. shivering) and are therefore at risk for hypothermia. These brown fat mitochondria contain more thermogenin than other cells, allowing for increased inner mitochondrial membrane disruption and proton leakage.&#x000a0;<xref ref-type="bibr" rid="article-20982.r21">[21]</xref><xref ref-type="bibr" rid="article-20982.r22">[22]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Oxidative Phosphorylation Inhibitors</bold>
</p>
        <p>Certain poisons can inhibit cellular oxidative phosphorylation such as rotenone, carboxin, antimycin A, cyanide, carbon monoxide (CO), sodium azide, and oligomycin. Rotenone inhibits complex I, carboxin inhibits complex II, antimycin A inhibits complex III, and cyanide and CO inhibit complex IV. Oligomycin inhibits ATP synthase.<xref ref-type="bibr" rid="article-20982.r23">[23]</xref><xref ref-type="bibr" rid="article-20982.r24">[24]</xref></p>
        <p>
<italic toggle="yes">Rotenone (and some barbiturates) &#x02013; inhibits complex I (coenzyme Q binding site)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Rotenone is a broadly used pesticide, but more often in the US as a piscicide (fish). Rotenone blocks complex I from passing electrons from the Fe-S clusters to ubiquinone. It is poorly absorbed through the skin, but rarely deadly as poisoning can cause vomiting and removal of the substance. However, purposeful ingestion can be fatal.&#x000a0;<xref ref-type="bibr" rid="article-20982.r25">[25]</xref><xref ref-type="bibr" rid="article-20982.r26">[26]</xref></p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Carboxin &#x02013; inhibits complex II (coenzyme Q binding site)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Carboxin is a fungicide that is no longer in use because of newer, more broad-spectrum agents. Similar to rotenone, carboxin&#x000a0;interferes with ubiquinone at the binding site.</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Doxorubicin &#x02013; coenzyme Q (theoretical)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Doxorubicin is used in cancer chemotherapy, typically breast and bladder carcinomas, and lymphoma. A well-known side effect of doxorubicin is dilated cardiomyopathy. One proposed mechanism of causation is the generation of reactive oxygen species within myocardial tissue as the drug interferes with electron transfer by coenzyme Q.&#x000a0;<xref ref-type="bibr" rid="article-20982.r27">[27]</xref></p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Antimycin A &#x02013; inhibits complex III (cytochrome c reductase)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Antimycin A is a piscicide that binds to cytochrome c reductase at the Qi binding site. This activity prevents ubiquinone from binding and accepting an electron, thereby blocking the recycling of ubiquinol (CoQH2) by the Q cycle.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Carbon Monoxide (CO) &#x02013; inhibits&#x000a0;complex IV (cytochrome c oxidase)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Carbon monoxide binds to and inhibits cytochrome c oxidase (complex IV). In addition to the disruption of the ETC, carbon monoxide also binds to hemoglobin at an oxygen-binding site converting it to carboxyhemoglobin. In this state, oxygen is displaced from hemoglobin, effectively blocking delivery to body tissues. The cardiac and central nervous systems, both organ systems which are highly dependent on oxygen consumption, manifest the common signs of CO poisoning. Symptoms such as tachycardia, hypotension, or arrhythmias may couple with fatigue, headache, nausea, vomiting, and changes in vision. More serious cases may display seizure, coma, retinal hemorrhages, or a characteristic cherry-red blood hue of the skin, though more often useful on autopsy (caution is critical: some patients may appear "normal" rather than pale/dusky because of inadequate tissue oxygenation).<xref ref-type="bibr" rid="article-20982.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Sources of CO are paint strippers, house fires, wood-burning stoves, automobile exhaust, and other gasoline- or propane-fueled equipment. A CO saturation monitor can detect CO levels. Ratios of carboxyhemoglobin to hemoglobin greater than 10% are likely to show as symptomatic. Regular pulse oximetry devices read the percent of bound hemoglobin, irrespective of what is bound. Therefore, when CO is bound rather than O2, a patient's pulse Ox may still appear normal and cannot be used reliably. Instead, a co-oximeter should be used. Treatment for CO poisoning is to dissociate the bound CO with O2. Providing 100% supplemental oxygen via non-rebreather or administering hyperbaric oxygen are options.<xref ref-type="bibr" rid="article-20982.r29">[29]</xref><xref ref-type="bibr" rid="article-20982.r30">[30]</xref><xref ref-type="bibr" rid="article-20982.r31">[31]</xref></p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Cyanide (CN) &#x02013; inhibits complex IV (cytochrome c oxidase)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cyanide also binds to and inhibits cytochrome c oxidase (complex IV). Similar symptoms as a result of tissue hypoxia can present in affected patients. In contrast, these patients tend to have hypoxia that is not responsive to supplemental O2 and an almond breath odor. Typical sources of cyanide include house fires (furniture or rugs), jewelry cleaning solutions, plastic or rubber manufacturing, iatrogenic from prescribed nitroprusside, or even some fruit seeds (apricots, peaches, apples).</p>
          </list-item>
          <list-item>
            <p>Treatment can include nitrites to oxidize hemoglobin iron from Fe2+ to Fe3+, also known as methemoglobin, a conformation that binds cyanide, preventing it from contacting the ETC. However, this prevents blood cells from transporting oxygen, therefore requiring further treatment with methylene blue to reduce Fe3+ back to Fe2+. Another option is administering hydroxocobalamin, a form of vitamin B12, or thiosulfate, although thiosulfate is not time efficient and typically requires combination therapy with nitrites.<xref ref-type="bibr" rid="article-20982.r32">[32]</xref></p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Oligomycin &#x02013; inhibits ATP-synthase (complex V)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Oligomycin is a macrolide antibiotic synthesized by Streptomyces species that inhibits the F0 subunit of ATP-synthase, preventing ATP production. Its predominant use is for research purposes.<xref ref-type="bibr" rid="article-20982.r33">[33]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20982.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20982&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20982">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20982/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20982">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20982.s7">
        <fig id="article-20982.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Electron Transport Chain graphic. Shows Inter-membrane space, inner membrane and matrix areas Illustration by Emma Gregory</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Electron_Transport_Chain__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20982.s8">
        <title>References</title>
        <ref id="article-20982.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lencina</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Franza</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ulett</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Ipe</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Gaudu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gennis</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Schurig-Briccio</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Type 2 NADH Dehydrogenase Is the Only Point of Entry for Electrons into the Streptococcus agalactiae Respiratory Chain and Is a Potential Drug Target.</article-title>
            <source>mBio</source>
            <year>2018</year>
            <month>Jul</month>
            <day>03</day>
            <volume>9</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">29970468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirst</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Towards the molecular mechanism of respiratory complex I.</article-title>
            <source>Biochem J</source>
            <year>2009</year>
            <month>Dec</month>
            <day>23</day>
            <volume>425</volume>
            <issue>2</issue>
            <fpage>327</fpage>
            <page-range>327-39</page-range>
            <pub-id pub-id-type="pmid">20025615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sazanov</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Hinchliffe</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus.</article-title>
            <source>Science</source>
            <year>2006</year>
            <month>Mar</month>
            <day>10</day>
            <volume>311</volume>
            <issue>5766</issue>
            <fpage>1430</fpage>
            <page-range>1430-6</page-range>
            <pub-id pub-id-type="pmid">16469879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirst</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Energy transduction by respiratory complex I--an evaluation of current knowledge.</article-title>
            <source>Biochem Soc Trans</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>Pt 3</issue>
            <fpage>525</fpage>
            <page-range>525-9</page-range>
            <pub-id pub-id-type="pmid">15916556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yankovskaya</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Horsefield</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>T&#x000f6;rnroth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Luna-Chavez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Miyoshi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>L&#x000e9;ger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cecchini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Iwata</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Architecture of succinate dehydrogenase and reactive oxygen species generation.</article-title>
            <source>Science</source>
            <year>2003</year>
            <month>Jan</month>
            <day>31</day>
            <volume>299</volume>
            <issue>5607</issue>
            <fpage>700</fpage>
            <page-range>700-4</page-range>
            <pub-id pub-id-type="pmid">12560550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horsefield</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Iwata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Complex II from a structural perspective.</article-title>
            <source>Curr Protein Pept Sci</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>107</fpage>
            <page-range>107-18</page-range>
            <pub-id pub-id-type="pmid">15078221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geertman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>van Maris</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>van Dijken</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Pronk</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Physiological and genetic engineering of cytosolic redox metabolism in Saccharomyces cerevisiae for improved glycerol production.</article-title>
            <source>Metab Eng</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>532</fpage>
            <page-range>532-42</page-range>
            <pub-id pub-id-type="pmid">16891140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thorpe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Structure and mechanism of action of the acyl-CoA dehydrogenases.</article-title>
            <source>FASEB J</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>718</fpage>
            <page-range>718-25</page-range>
            <pub-id pub-id-type="pmid">7601336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Benlekbir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Venkatakrishnan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hosler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tajkhorshid</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rubinstein</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Gennis</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Structure of the alternative complex III in a supercomplex with cytochrome oxidase.</article-title>
            <source>Nature</source>
            <year>2018</year>
            <month>May</month>
            <volume>557</volume>
            <issue>7703</issue>
            <fpage>123</fpage>
            <page-range>123-126</page-range>
            <pub-id pub-id-type="pmid">29695868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iwata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Iwata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Ramaswamy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jap</surname>
                <given-names>BK</given-names>
              </name>
            </person-group>
            <article-title>Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex.</article-title>
            <source>Science</source>
            <year>1998</year>
            <month>Jul</month>
            <day>03</day>
            <volume>281</volume>
            <issue>5373</issue>
            <fpage>64</fpage>
            <page-range>64-71</page-range>
            <pub-id pub-id-type="pmid">9651245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trumpower</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex.</article-title>
            <source>J Biol Chem</source>
            <year>1990</year>
            <month>Jul</month>
            <day>15</day>
            <volume>265</volume>
            <issue>20</issue>
            <fpage>11409</fpage>
            <page-range>11409-12</page-range>
            <pub-id pub-id-type="pmid">2164001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hunte</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Palsdottir</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Trumpower</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Protonmotive pathways and mechanisms in the cytochrome bc1 complex.</article-title>
            <source>FEBS Lett</source>
            <year>2003</year>
            <month>Jun</month>
            <day>12</day>
            <volume>545</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-46</page-range>
            <pub-id pub-id-type="pmid">12788490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calhoun</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Gennis</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>The cytochrome oxidase superfamily of redox-driven proton pumps.</article-title>
            <source>Trends Biochem Sci</source>
            <year>1994</year>
            <month>Aug</month>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>325</fpage>
            <page-range>325-30</page-range>
            <pub-id pub-id-type="pmid">7940677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt-Rohr</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Oxygen Is the High-Energy Molecule Powering Complex Multicellular Life: Fundamental Corrections to Traditional Bioenergetics.</article-title>
            <source>ACS Omega</source>
            <year>2020</year>
            <month>Feb</month>
            <day>11</day>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>2221</fpage>
            <page-range>2221-2233</page-range>
            <pub-id pub-id-type="pmid">32064383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lovero</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marsano</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Sanchez-Martinez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boukhatmi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Drechsler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oliva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Whitworth</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Porcelli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Caggese</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Characterization of Drosophila ATPsynC mutants as a new model of mitochondrial ATP synthase disorders.</article-title>
            <source>PLoS One</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>e0201811</fpage>
            <pub-id pub-id-type="pmid">30096161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okuno</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Iino</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Noji</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Rotation and structure of FoF1-ATP synthase.</article-title>
            <source>J Biochem</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>149</volume>
            <issue>6</issue>
            <fpage>655</fpage>
            <page-range>655-64</page-range>
            <pub-id pub-id-type="pmid">21524994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Junge</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>ATP synthase.</article-title>
            <source>Annu Rev Biochem</source>
            <year>2015</year>
            <volume>84</volume>
            <fpage>631</fpage>
            <page-range>631-57</page-range>
            <pub-id pub-id-type="pmid">25839341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hinkle</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>P/O ratios of mitochondrial oxidative phosphorylation.</article-title>
            <source>Biochim Biophys Acta</source>
            <year>2005</year>
            <month>Jan</month>
            <day>07</day>
            <volume>1706</volume>
            <issue>1-2</issue>
            <fpage>1</fpage>
            <page-range>1-11</page-range>
            <pub-id pub-id-type="pmid">15620362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barrett</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roshankar</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Alsop</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Belanger</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Huynh</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ku&#x0010d;erka</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rheinst&#x000e4;dter</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Interaction of aspirin (acetylsalicylic acid) with lipid membranes.</article-title>
            <source>PLoS One</source>
            <year>2012</year>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>e34357</fpage>
            <pub-id pub-id-type="pmid">22529913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warrick</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Smolinske</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aaron</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A 29-year analysis of acute peak salicylate concentrations in fatalities reported to United States poison centers.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>56</volume>
            <issue>9</issue>
            <fpage>846</fpage>
            <page-range>846-851</page-range>
            <pub-id pub-id-type="pmid">29431532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cinti</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The adipose organ.</article-title>
            <source>Prostaglandins Leukot Essent Fatty Acids</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>73</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-15</page-range>
            <pub-id pub-id-type="pmid">15936182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Enerb&#x000e4;ck</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The origins of brown adipose tissue.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>May</month>
            <day>07</day>
            <volume>360</volume>
            <issue>19</issue>
            <fpage>2021</fpage>
            <page-range>2021-3</page-range>
            <pub-id pub-id-type="pmid">19420373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Faraldo-G&#x000f3;mez</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Membrane plasticity facilitates recognition of the inhibitor oligomycin by the mitochondrial ATP synthase rotor.</article-title>
            <source>Biochim Biophys Acta Bioenerg</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>1859</volume>
            <issue>9</issue>
            <fpage>789</fpage>
            <page-range>789-796</page-range>
            <pub-id pub-id-type="pmid">29630891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamalian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Jolly</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Snoeys</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Simic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Monshouwer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Kevin Park</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chadwick</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity.</article-title>
            <source>Toxicol In Vitro</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>53</volume>
            <fpage>136</fpage>
            <page-range>136-147</page-range>
            <pub-id pub-id-type="pmid">30096366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wood</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Alsahaf</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Streete</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dargan</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Fatality after deliberate ingestion of the pesticide rotenone: a case report.</article-title>
            <source>Crit Care</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>R280</fpage>
            <page-range>R280-4</page-range>
            <pub-id pub-id-type="pmid">15987402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lupescu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jilani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zbidah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Induction of apoptotic erythrocyte death by rotenone.</article-title>
            <source>Toxicology</source>
            <year>2012</year>
            <month>Oct</month>
            <day>28</day>
            <volume>300</volume>
            <issue>3</issue>
            <fpage>132</fpage>
            <page-range>132-7</page-range>
            <pub-id pub-id-type="pmid">22727881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallace</surname>
                <given-names>KB</given-names>
              </name>
            </person-group>
            <article-title>Doxorubicin-induced cardiac mitochondrionopathy.</article-title>
            <source>Pharmacol Toxicol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>93</volume>
            <issue>3</issue>
            <fpage>105</fpage>
            <page-range>105-15</page-range>
            <pub-id pub-id-type="pmid">12969434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weaver</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice. Carbon monoxide poisoning.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Mar</month>
            <day>19</day>
            <volume>360</volume>
            <issue>12</issue>
            <fpage>1217</fpage>
            <page-range>1217-25</page-range>
            <pub-id pub-id-type="pmid">19297574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tamaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Tsutsumi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Okajima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Katsumata</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Determination of total hemoglobin in forensic blood samples with special reference to carboxyhemoglobin analysis.</article-title>
            <source>Forensic Sci Int</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-96</page-range>
            <pub-id pub-id-type="pmid">2279722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barker</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Tremper</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>The effect of carbon monoxide inhalation on pulse oximetry and transcutaneous PO2.</article-title>
            <source>Anesthesiology</source>
            <year>1987</year>
            <month>May</month>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>677</fpage>
            <page-range>677-9</page-range>
            <pub-id pub-id-type="pmid">3578881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raub</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mathieu-Nolf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hampson</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Thom</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Carbon monoxide poisoning--a public health perspective.</article-title>
            <source>Toxicology</source>
            <year>2000</year>
            <month>Apr</month>
            <day>07</day>
            <volume>145</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-14</page-range>
            <pub-id pub-id-type="pmid">10771127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jensen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Aasa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Malmstr&#x000f6;m</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Cyanide inhibition of cytochrome c oxidase. A rapid-freeze e.p.r. investigation.</article-title>
            <source>Biochem J</source>
            <year>1984</year>
            <month>Dec</month>
            <day>15</day>
            <volume>224</volume>
            <issue>3</issue>
            <fpage>829</fpage>
            <page-range>829-37</page-range>
            <pub-id pub-id-type="pmid">6098268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20982.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shchepina</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Pletjushkina</surname>
                <given-names>OY</given-names>
              </name>
              <name>
                <surname>Avetisyan</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Bakeeva</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Fetisova</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Izyumov</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Saprunova</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Vyssokikh</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Chernyak</surname>
                <given-names>BV</given-names>
              </name>
              <name>
                <surname>Skulachev</surname>
                <given-names>VP</given-names>
              </name>
            </person-group>
            <article-title>Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis.</article-title>
            <source>Oncogene</source>
            <year>2002</year>
            <month>Nov</month>
            <day>21</day>
            <volume>21</volume>
            <issue>53</issue>
            <fpage>8149</fpage>
            <page-range>8149-57</page-range>
            <pub-id pub-id-type="pmid">12444550</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
